Medical Devices Market Size, Share, and Trends 2024 to 2034

The global medical devices market size is calculated at USD 678.88 billion in 2025 and is expected to reach around USD 1,146.95 billion by 2034, expanding at a CAGR of 6% from 2025 to 2034. The North America medical devices market size reached USD 256.18 billion in 2024 and is expanding at a CAGR of 6.05% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1129
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Devices Market 

5.1. COVID-19 Landscape: Medical Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Devices Market, By Product

8.1. Medical Devices Market, by Product Type, 2025-2034

8.1.1. Monitoring Devices

8.1.1.1. Market Revenue and Forecast (2022-2034)

8.1.2. Diagnostic Devices

8.1.2.1. Market Revenue and Forecast (2022-2034)

8.1.3. Surgical ENT Devices

8.1.3.1. Market Revenue and Forecast (2022-2034)

8.1.4. Endoscopes

8.1.4.1. Market Revenue and Forecast (2022-2034)

8.1.5. Imaging Devices

8.1.5.1. Market Revenue and Forecast (2022-2034)

8.1.6. Diagnostic Molecular Devices

8.1.6.1. Market Revenue and Forecast (2022-2034)

8.1.7. Drug Delivery Devices

8.1.7.1. Market Revenue and Forecast (2022-2034)

8.1.8. Surgical Devices

8.1.8.1. Market Revenue and Forecast (2022-2034)

8.1.9. Bio Implants and Stimulation Devices

8.1.9.1. Market Revenue and Forecast (2022-2034)

8.1.10. Surgical ENT Devices.

8.1.10.1. Market Revenue and Forecast (2022-2034)

8.1.11. Treatment Equipment

8.1.11.1. Market Revenue and Forecast (2022-2034)

8.1.12. Infusion Pumps

8.1.12.1. Market Revenue and Forecast (2022-2034)

8.1.13. Medical lasers and LASIK Surgical Machines

8.1.13.1. Market Revenue and Forecast (2022-2034)

8.1.14. Drug Delivery Devices

8.1.14.1. Market Revenue and Forecast (2022-2034)

8.1.15. Others

8.1.15.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Medical Devices Market, By Therapeutic Application

9.1. Medical Devices Market, by Therapeutic Application, 2025-2034

9.1.1. Gastrointestinal surgery

9.1.1.1. Market Revenue and Forecast (2022-2034)

9.1.2. General Surgery

9.1.2.1. Market Revenue and Forecast (2022-2034)

9.1.3. Diagnostic Imaging

9.1.3.1. Market Revenue and Forecast (2022-2034)

9.1.4. Respiratory

9.1.4.1. Market Revenue and Forecast (2022-2034)

9.1.5. Orthopedics

9.1.5.1. Market Revenue and Forecast (2022-2034)

9.1.6. Cardiovascular

9.1.6.1. Market Revenue and Forecast (2022-2034)

9.1.7. Dental

9.1.7.1. Market Revenue and Forecast (2022-2034)

9.1.8. Neurology

9.1.8.1. Market Revenue and Forecast (2022-2034)

9.1.9. Ophthalmology

9.1.9.1. Market Revenue and Forecast (2022-2034)

9.1.10. Ear-Nose-Throat (ENT)

9.1.10.1. Market Revenue and Forecast (2022-2034)

9.1.11. Nephrology and Urology

9.1.11.1. Market Revenue and Forecast (2022-2034)

9.1.12. Others

9.1.12.1. Market Revenue and Forecast (2022-2034)

Chapter 10. Global Medical Devices Market, By End User 

10.1. Medical Devices Market, by End User, 2025-2034

10.1.1. Hospitals & Clinics

10.1.1.1. Market Revenue and Forecast (2022-2034)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast (2022-2034)

10.1.3. Research laboratory

10.1.3.1. Market Revenue and Forecast (2022-2034)

10.1.4. Pharmaceutical Companies

10.1.4.1. Market Revenue and Forecast (2022-2034)

Chapter 11. Global Medical Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2022-2034)

11.1.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.1.3. Market Revenue and Forecast, by End User (2022-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2022-2034)

11.1.4.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.1.4.3. Market Revenue and Forecast, by End User (2022-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2022-2034)

11.1.5.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.1.5.3. Market Revenue and Forecast, by End User (2022-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2022-2034)

11.2.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.2.3. Market Revenue and Forecast, by End User (2022-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2022-2034)

11.2.4.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.2.4.3. Market Revenue and Forecast, by End User (2022-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2022-2034)

11.2.5.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.2.5.3. Market Revenue and Forecast, by End User (2022-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2022-2034)

11.2.6.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.2.6.3. Market Revenue and Forecast, by End User (2022-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2022-2034)

11.2.7.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.2.7.3. Market Revenue and Forecast, by End User (2022-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2022-2034)

11.3.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.3.3. Market Revenue and Forecast, by End User (2022-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2022-2034)

11.3.4.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.3.4.3. Market Revenue and Forecast, by End User (2022-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2022-2034)

11.3.5.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.3.5.3. Market Revenue and Forecast, by End User (2022-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2022-2034)

11.3.6.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.3.6.3. Market Revenue and Forecast, by End User (2022-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2022-2034)

11.3.7.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.3.7.3. Market Revenue and Forecast, by End User (2022-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2022-2034)

11.4.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.4.3. Market Revenue and Forecast, by End User (2022-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2022-2034)

11.4.4.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.4.4.3. Market Revenue and Forecast, by End User (2022-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2022-2034)

11.4.5.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.4.5.3. Market Revenue and Forecast, by End User (2022-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2022-2034)

11.4.6.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.4.6.3. Market Revenue and Forecast, by End User (2022-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2022-2034)

11.4.7.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.4.7.3. Market Revenue and Forecast, by End User (2022-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2022-2034)

11.5.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.5.3. Market Revenue and Forecast, by End User (2022-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2022-2034)

11.5.4.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.5.4.3. Market Revenue and Forecast, by End User (2022-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2022-2034)

11.5.5.2. Market Revenue and Forecast, by Therapeutic Application (2022-2034)

11.5.5.3. Market Revenue and Forecast, by End User (2022-2034)

Chapter 12. Company Profiles

12.1. Medtronics Plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Johnson & Johnson

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Fesenius Medical Care

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. DePuy Synthes

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GE Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Philips Healthcare

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Ethicon LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Siemens Healthineers AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Stryker

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Cardinal Health

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

12.12. Baxter International Inc.

12.12.1. Company Overview

12.12.2. Product Offerings

12.12.3. Financial Performance

12.12.4. Recent Initiatives

12.13. BD

12.13.1. Company Overview

12.13.2. Product Offerings

12.13.3. Financial Performance

12.13.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global medical devices market size was valued at USD 640.45 billion in 2024 and expected to be worth around USD 1,146.95 billion by 2034.

The global medical devices market is growing at a compound annual growth rate (CAGR) of 6% during the forecast period 2025 to 2034.

The increasing prevalence of chronic diseases that include cancer and diabetes expected to contribute prominently in driving the medical devices market. Furthermore, unhealthy lifestyle and eating habits also attracts other types of critical diseases that further expected to flourish the demand for medical devices in the near future.

In 2024, North America captured the largest revenue share and anticipated to continue its dominance over the upcoming years because of developed healthcare infrastructure.

The Asia Pacific emerged as the fastest growing region during the forecast period owing to rising ageing population, increasing per capita income, and growing health concern among the people.

The major key players operating in medical devices market are DePuy Synthes, Medtronics Plc, Fesenius Medical Care, GE Healthcare, Philips Healthcare, Ethicon LLC, Siemens Healthineers, Stryker, Cardinal Health, Baxter International Inc., BD among others.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client